DOTA-RGDV，DOTA偶联多肽RGDV

名称：DOTA-RGDV，DOTA偶联多肽RGDV

Studies using a baboon model showed that RGDV selectively inhibits platelet-dependent thrombus formation in vivo. In a study by Kawahara et al. on the inhibitory effects of adhesion oligopeptides on the invasion of squamous carcinoma cells RGDV was the most effective inhibitor amongst the evaluated peptides.

RGDV 是一种四肽，可将附着的化合物递送至血栓或肿瘤细胞等靶点，它增强了***和抗聚集或抗粘连化合物的功效。 RDGV 结合细胞表面的整合素并防止纤维蛋白原与血小板结合。

RGDV is a tetrapeptide that delivers attached compounds to targets such as thrombus or tumor cells; it enhances efficacy of anticancer and anti-aggregation or anti-adhesion compounds. RDGV binds integrins on the surfaces of cells and prevents binding of fibrinogen to platelets.

中文名称：RGDV

英文名：RGDV

CAS号：93674-99-8

单字母：H2N-RGDV-OH

三字母：H2N-Arg-Gly-Asp-Val-COOH

氨基酸个数：4

分子式：C17H31N7O7

平均分子量：445.47

***分子量：445.23

等电点(PI)：6.34

pH=7.0时的净电荷数：-0.02

平均亲水性：1.5

疏水性值：-1.05

来源：Synthetic

纯度：95%、98%

盐体系：可选TFA、HAc、HCl或其它

生成周期：2-3周

储存条件：-20 ± 5 °C

相关试剂列表：

DOTA-(CONH2)3      913528-04-8

DOTA-(COOt-Bu)3      137076-54-1

DOTA-(COOt-Bu)3-azide      1402795-92-9

DOTA-(COOt-Bu)3-butyne      2125661-54-1

DOTA-(COOt-Bu)3-C2-NH2      173308-19-5

DOTA-(COOt-Bu)3-C4-NH2      1402393-59-2

DOTA-(COOt-Bu)3-Mal      1613382-10-7

DOTA-(COOt-Bu)3-NHFmoc-Lys      479081-06-6

DOTA mono-NHS ester      170908-81-3

DOTA-(COOt-Bu)3-NHS      819869-77-7